Skip to main content
SB

Spiritus Bioscience

Spiritus Biosciences develops proprietary drug delivery systems utilizing novel formulation techniques to enhance the efficacy and safety of psychedelic therapeutics for mental health and neuropsychiatric disorders. Their clinical trial design significantly reduces data collection time and costs, facilitating faster development of treatments with fewer adverse effects.

Ala, United StatesFounded 2023310+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Existing psychedelic therapies for mental health and neuropsychiatric disorders often suffer from variable efficacy, significant side effects, and inconvenient administration routes, hindering patient acceptance and treatment outcomes. Traditional clinical trials for these therapies are lengthy and expensive, slowing the development of improved treatments.

Solution

Spiritus Biosciences is developing proprietary drug delivery systems designed to enhance the efficacy, safety, and patient experience of psychedelic therapeutics. By utilizing novel formulation techniques and final form technology, they aim to optimize drug absorption, reduce adverse effects, and improve treatment adherence. Their approach focuses on contouring drug delivery to meet specific patient needs, potentially leading to more effective and patient-friendly therapies. Furthermore, Spiritus Biosciences employs a unique clinical trial design intended to accelerate the development process and reduce associated costs.

Target Audience

The primary target audience includes patients suffering from mental health and neuropsychiatric disorders who could benefit from improved psychedelic therapies, as well as clinicians and researchers seeking more effective and safer treatment options.

Features

  • Novel formulation techniques to improve drug absorption and bioavailability.
  • Proprietary drug delivery systems tailored for psychedelic therapeutics.
  • Focus on reducing adverse effects and enhancing patient tolerability.
  • Streamlined clinical trial design for faster and more cost-effective development.
  • Patentable drug delivery products addressing unmet needs in mental health.
This profile is AI-generated and may contain inaccuracies.